- Home
- SNTI vs ISPO Comparison
SNTI vs ISPO Comparison
Compare SNTI & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- ISPO
- Stock Information
- Founded
- SNTI 2016
- ISPO 2010
- Country
- SNTI United States
- ISPO United States
- Employees
- SNTI N/A
- ISPO N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- ISPO Blank Checks
- Sector
- SNTI Health Care
- ISPO Finance
- Exchange
- SNTI Nasdaq
- ISPO Nasdaq
- Market Cap
- SNTI 39.6M
- ISPO 44.3M
- IPO Year
- SNTI N/A
- ISPO N/A
- Fundamental
- Price
- SNTI $1.56
- ISPO $3.08
- Analyst Decision
- SNTI Strong Buy
- ISPO
- Analyst Count
- SNTI 2
- ISPO 0
- Target Price
- SNTI $8.50
- ISPO N/A
- AVG Volume (30 Days)
- SNTI 107.2K
- ISPO 31.3K
- Earning Date
- SNTI 08-07-2025
- ISPO 08-12-2025
- Dividend Yield
- SNTI N/A
- ISPO N/A
- EPS Growth
- SNTI N/A
- ISPO N/A
- EPS
- SNTI N/A
- ISPO N/A
- Revenue
- SNTI N/A
- ISPO $261,225,000.00
- Revenue This Year
- SNTI N/A
- ISPO N/A
- Revenue Next Year
- SNTI $150.00
- ISPO $148.66
- P/E Ratio
- SNTI N/A
- ISPO N/A
- Revenue Growth
- SNTI N/A
- ISPO N/A
- 52 Week Low
- SNTI $1.46
- ISPO $2.19
- 52 Week High
- SNTI $16.94
- ISPO $7.17
- Technical
- Relative Strength Index (RSI)
- SNTI 37.24
- ISPO 52.94
- Support Level
- SNTI $1.52
- ISPO $2.85
- Resistance Level
- SNTI $1.65
- ISPO $3.10
- Average True Range (ATR)
- SNTI 0.10
- ISPO 0.23
- MACD
- SNTI 0.03
- ISPO 0.03
- Stochastic Oscillator
- SNTI 50.00
- ISPO 68.66
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.